Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
tDCS and XingNaoJing for Consciousness Disorders
NCT06927336Phase 4Not yet recruiting
- Sponsor
- Second Affiliated Hospital of Kunming Medical University
- Start
- Apr 2025
- Primary completion
- Jun 2026
- Modality
- HM (Herbal Medicine), Combination Drug
- Countries
- 1
01
Overview
Phase 4, randomised trial of Xingnaojing in disorder of consciousness (DOC) (3 arms), sponsored by Second Affiliated Hospital of Kunming Medical University. Primary endpoints: electroencephalogram at 2 weeks and Oxygenated hemoglobin concentration at 2 weeks. Planned start Apr 2025; status: not yet recruiting.
02
Drugs
Xingnaojing
03
Conditions
disorder of consciousness (DOC)
Beyond the preview
Go deeper on NCT06927336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06927336.